ArticleClinicoEconomics and outcomes research : CEOR2013

Leuprolide acetate 1-, 3- and 6-monthly depot formulations in androgen deprivation therapy for prostate cancer in nine European countries: evidence review and economic evaluation.

Jaro Wex et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.